The contribution of adipose tissue gene regulation to obesity related pathogenes...
The contribution of adipose tissue gene regulation to obesity related pathogenesis
Obesity is major challenge for healthcare worldwide and is linked to increased risk for type 2 diabetes and cardiovascular disease. However not all obese individuals are equally vulnerable and it has long been appreciated that cen...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
EpiFAT
Epigenomic Reprogramming of Adipose Tissue Function and Ener...
2M€
Cerrado
SAF2009-09364
ESTUDIO DE NUEVOS GENES IMPLICADOS EN LA PATOLOGIA DE LA OBE...
151K€
Cerrado
ADIPODIF
Adipocyte Differentiation and Metabolic Functions in Obesity...
2M€
Cerrado
SAT-IMG
ABDOMINAL SUBCUTANEOUS ADIPOSE TISSUE DEPOTS AND HUMAN METAB...
209K€
Cerrado
ADIBET
The role of adipose tissue in obesity beta cell crosstalk
1M€
Cerrado
SAF2012-33014
ALTERACIONES DE LA DISTRIBUCION DEL TEJIDO ADIPOSO HUMANO DE...
94K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Obesity is major challenge for healthcare worldwide and is linked to increased risk for type 2 diabetes and cardiovascular disease. However not all obese individuals are equally vulnerable and it has long been appreciated that central obesity (an excess of visceral fat) comprises a major risk factor for disease. It is also well established that adipose tissue from different parts of the body displays distinct biochemical properties, with biological profiles of subcutaneous and visceral fat being clearly distinguishable. It is likely that the biological mechanisms that govern these differences are, in part, responsible for rendering visceral fat a risk factor for disease. Given the need to understand the critical differences between adipose depots, the project I propose aims to identify key differences in the biology of subcutaneous and visceral fat, by addressing the fraction of genetic variants that contribute to this through a regulatory effect. To achieve this, mRNA will be extracted from subcutaneous and visceral adipose tissue from an initial sample of 50 individuals and will be sequenced using next generation sequencing. DNA will be extracted from lymphoblastoid cell lines from the same individuals and will be genotyped. Expression quantitative trait loci with an impact on cis gene expression will be identified through association of single nucleotide polymorphism genotypes with expression levels. Furthermore, chromatin will be extracted from subcutaneous and visceral fat from five individuals, and regions of open chromatin will be identified through formaldehyde-assisted isolation of regulatory elements. Integrating data on regulatory variation and open chromatin is an important way forward. This approach allows formulation of hypotheses regarding function outside of coding regions and is likely to lead to the identification of genetic variants that have a role in influencing susceptibility to obesity-related disorders.